@MAGICFoundation

Annual Convention Program
FDA approves Novo Nordisk's Sogroya® as the first and only once-weekly, long-acting growth hormone for three additional pediatric indications
FDA approves Novo Nordisk's Sogroya® as the first and only once-weekly, long-acting growth hormone for three additional pediatric indications
Redefining ISS: Improving Confidence and Clarity Launch Event Tickets, Tue, Jan 27, 2026 at 4:30 PM | Eventbrite
Redefining ISS: Improving Confidence and Clarity Launch Event Tickets, Tue, Jan 27, 2026 at 4:30 PM | Eventbrite
Join MAGIC's Family Network — MAGIC Foundation for Children's Growth
Donate to Our Convention Raffle
Donate to Our Convention Raffle
Rare Patient Voices Sign Up
Rare Patient Voices Sign Up
MAGIC Foundation Website
MAGIC Foundation Facebook

View on mobile